Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Autologous Extracellular Matrix-Based Cell-Free Therapy for Tissue Regeneration Through Trem2<sup>+</sup> Macrophages Mediated Angiogenesis

Hou M., Shi N., Guo Y., Tang J., Peng H., Liang B.

Laboratory Study on Chronic Wound, published in Exploration (Beijing) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Exploration (Beijing) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42016748
PMCID
PMC13094522
DOI
10.1002/exp.20250031

Abstract (original English)

The extracellular matrix (ECM) is vital for tissue regeneration and remodeling by providing structural support and regulating cell behavior. Bioactive membranes derived from decellularized ECM show promising regenerative potential in many fields. However, they still face challenges such as immune rejection, structural disparities, and high costs associated with human-derived materials. These issues hinder their widespread clinical application and limit their adaptability to personalized treatments. Further research is needed to improve the safety, efficacy, and accessibility of ECM-based materials. This study develops an autologous ECM-based membrane, termed adipose-derived matrix film (ADF), using a simple physical method inspired by traditional " papermaking ." ADF exhibits favorable biological activity and mechanical strength, essential for tissue regeneration. Its production is efficient, facilitating clinical translation. Additionally, ADF can be stored long-term at low temperatures, enabling the establishment of an " ECM bank " for personalized medicine. As a cell-free therapy, ADF enhances soft tissue regeneration and wound healing, with Trem2 + macrophages playing a key role in neovascularization. We introduce a novel autologous adipose ECM-derived bio-membrane, offering new perspectives on ECM preservation and Trem2 + macrophage-mediated regeneration. These findings si

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research